Trials / Recruiting
RecruitingNCT07281781
Treating Anemia in Myelofibrosis With Repurposed Drugs (Nelfinavir) That Restore Iron Delivery to the Bone Marrow
- Status
- Recruiting
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 10 (estimated)
- Sponsor
- University of California, Irvine · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a phase I/II protocol investigating whether Nelfinavir can improve anemia and lower serum fibrosis biomarkers in Myelofibrosis patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Nelfinavir | Taken twice daily |
Timeline
- Start date
- 2025-09-16
- Primary completion
- 2026-06-01
- Completion
- 2027-06-01
- First posted
- 2025-12-15
- Last updated
- 2026-02-04
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT07281781. Inclusion in this directory is not an endorsement.